Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person10
INVESTORS TITLE CO
Company
RMB INVESTORS TRUST
Company
Capital World Investors
Company
GAMCO INVESTORS, INC. ET AL
Company
BARINGS CORPORATE INVESTORS
Company
GENERAL AMERICAN INVESTORS CO INC
Company
U S GLOBAL INVESTORS INC
Company
SEI INVESTMENTS CO
Company
AB Private Credit Investors Corp
Company
TWO HARBORS INVESTMENT CORP.
Company
Primary record20
INVESTORS TITLE CO filed 8-K
Item 2.02. Results of Operations and Financial Condition Attached as Exhibit 99.1 and incorporated herein by reference is a copy of the press release of Investors Title Company, dated November 5, 2026, reporting Investor
TELEFLEX INC filed 8-K
Item 2.02. Results of Operations and Financial Condition. On November 5, 2026, Teleflex Incorporated (the “Company”) issued a press release (the “Press Release”) announcing its financial results for the quarter ended Sep
Vivakor, Inc. filed 8-K
Item 3.02 Unregistered Sales of Equity Securities. As previously reported, on February 27, 2026, the Company issued a junior secured convertible promissory note (the “Fourth Note”) to J.J. Astor & Co. (the “J.J. Astor”),
Allegiant Travel CO filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 4, 2026, Allegiant Travel Company (the “Company”) issued the press release attached as Exhibit 99.1 to this Form 8-K concerning our results of operatio
Dauch Corp filed 8-K
Item 2.02 Results of Operations and Financial Condition In light of requirements applicable to companies with a secondary listing on the London Stock Exchange, Dauch Corporation ("Dauch") (NYSE: DCH; LSE: DCH) is announc
American Fusion, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of Principal Executive Officer On October 26, 2026,
Strategy Inc filed 8-K
Item 2.02. Results of Operations and Financial Condition. On October 29, 2026, Strategy Inc (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended September 30, 2026. A co
KIORA PHARMACEUTICALS INC filed 8-K
Item 1.01. Entry Into a Material Definitive Agreement. On October 23, 2026, Kiora Pharmaceuticals, Inc. (the “Company”) entered into an Exclusive License Agreement (the “Agreement”) with Senju Pharmaceutical Co., Ltd. (“
Galaxy Gaming, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) and (d) On October 18, 2026, Meredith Brill notified the B
Disc Medicine, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 19, 2026, Disc Medicine, Inc. (the “Company”) issued a press release titled “Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 AP
Vivakor, Inc. filed 8-K
Item 3.02 Unregistered Sales of Equity Securities. As previously reported, on July 9, 2025, the Company issued a junior secured convertible promissory note (the Second Note ) to J.J. Astor & Co. (the J.J. Astor ), in the
EMERSON ELECTRIC CO filed 8-K
Item 2.02 Results of Operations and Financial Condition (Dollars in millions, except per share amounts) On October 13, 2026, Emerson Electric Co. ("Emerson" or the "Company") announced that, effective for the fiscal year
Vivakor, Inc. filed 8-K
Item 3.02 Unregistered Sales of Equity Securities. As previously reported, on July 9, 2025, the Company issued a junior secured convertible promissory note (the Second Note ) to J.J. Astor & Co. (the J.J. Astor ), in the
Matador Resources Co filed 8-K
Item 2.01 Completion of Acquisition or Disposition of Assets. On October 1, 2026, MRC Ranger, LLC ( Purchaser ), a wholly-owned subsidiary of Matador Resources Company ( Matador ), consummated the previously disclosed ac
ADARx Pharmaceuticals, Inc. filed 8-K
Item 3.02 Unregistered Sales of Equity Securities. On September 13, 2026, ADARx Pharmaceuticals, Inc. (the Company ) entered into a Common Stock Purchase Agreement with AbbVie Inc. (the Purchaser ) pursuant to which the
Fly-E Group, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 11, 2026, Lisa Fan resigned from her positions as
Vivakor, Inc. filed 8-K
Item 3.02 Unregistered Sales of Equity Securities. As previously reported, between June 6, 2025 and June 9, 2025, Vivakor, Inc. (the “Company”) issued convertible promissory notes (the “Lender Notes”), to seven non-affil
Lord Abbett Private Credit Fund S filed 8-K
Item 3.02. Unregistered Sales of Equity Securities. As of August 1, 2026, Lord Abbett Private Credit Fund S ( we , the Company or the Fund ), issued and sold approximately 209,520 of the Company s common shares of benefi
Lord Abbett Private Credit Fund filed 8-K
Item 3.02. Unregistered Sales of Equity Securities. As of August 1, 2026, Lord Abbett Private Credit Fund ( we , the Company or the Fund ) issued and sold approximately 3,249,536 of the Company s common shares of benefic
Future Vision II Acquisition Corp. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. The disclosures set forth under Item 2.03 are incorporated by reference. Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance She